Product correctly added to cart.

discount label
3,4-Dihydro-1,4-benzoxazepin-5(2H)-one
View 3D

Biosynth logo

3,4-Dihydro-1,4-benzoxazepin-5(2H)-one

CAS: 703-51-5

Ref. 3D-FD128171

1gTo inquire
2gTo inquire
5gTo inquire
10gTo inquire
25gTo inquire
Estimated delivery in United States, on Friday 10 Jan 2025

Product Information

Name:
3,4-Dihydro-1,4-benzoxazepin-5(2H)-one
Synonyms:
  • 1,4-benzoxazepin-5(2H)-one
  • 3,4-dihydro-
  • 3,4-dihydro-1,4-benzoxazepin-5(2H)-one
  • 3,4-Dihydrobenzo[f][1,4]oxazepin-5(2H)-one
Description:

3,4-Dihydro-1,4-benzoxazepin-5(2H)-one is a synthetic intermediate that can be used in the synthesis of protein kinase inhibitors. The compound was found to have a lowering effect on intraocular pressure (IOP) in animal models and may be useful for the treatment of glaucoma. The compound also has an inhibitory effect on class I, II, IV and V protein kinases. 3,4-Dihydro-1,4-benzoxazepin-5(2H)-one is selective for rho-associated protein kinase (ROCK), which is implicated in glaucoma pathology. This compound does not inhibit cyclooxygenase or lipoxygenase enzymes, which are key enzymes involved in inflammatory processes.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
163.17 g/mol
Formula:
C9H9NO2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FD128171 3,4-Dihydro-1,4-benzoxazepin-5(2H)-one

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".